Makers of new drugs exempt from price control: Govt.

The Indian Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) has notified an order amending the Drugs (Prices Control) Order 2013.

Effective January 3, 2019, manufacturers of new drugs patented in India are exempt from price control for a period of five years from the date of commencement of their commercial marketing in India.

The order also stated that drugs for treating orphan diseases as decided by the Ministry of Health and Family Welfare will also be exempt from price control.

Order can be accessed at https://bit.ly/2t4G4RF

About DSLegal

A full service international law firm based in New Delhi with an office in Chicago, USA.
This entry was posted in Consumer Law, Drugs Law, General Law, Intellectual Property Law, International Law, patent, patent law, TRIPS and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s